Research work · 2017

Tumor Mutational Burden and Response Rate to PD-1 Inhibition

Mark M. Yarchoan, Alexander C. Hopkins, Elizabeth M. Jaffee

New England Journal of Medicine

Abstract

In a survey of the spectrum of mutational burdens in 27 types of cancers, there was a correlation between an increased mutational burden and the response to checkpoint inhibition of PD-1 and PD-L1.

Download PDF

DOI: 10.1056/nejmc1713444